ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin’s lymphoma relapsing after autologous stem cell transplantation

Saved in:
Bibliographic Details
Published inAnnals of hematology Vol. 90; no. 8; pp. 971 - 973
Main Authors Tempescul, A., Ianotto, J. C., Eveillard, J. R., Guillerm, G., Berthou, C.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.08.2011
Springer Nature B.V
Springer Verlag
Subjects
Adult
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cisplatin - administration & dosage
Cytarabine - administration & dosage
Etoposide - administration & dosage
Hematology
Hematopoietic Stem Cell Transplantation
Hodgkin Disease - drug therapy
Hodgkin Disease - therapy
Humans
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Prednisone - administration & dosage
Recurrence
Remission Induction
Thalidomide - administration & dosage
Thalidomide - analogs & derivatives
Transplantation, Autologous
Autologous Stem Cell Transplantation
Therapeutic Programme
Lenalidomide
Thalidomide
Lenalidomide Treatment
Medicine
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-010-1107-x